The DirecT MeDical cosTs of Healthcare-Associated Infections in U . S . Hospitals and the Benefits of Prevention Author –

Nursing. Any errors are the sole responsibility of the author. Acknowledgement This report uses results from the published medical and economic literature to provide a range of estimates for the annual direct hospital cost of treating healthcare-associated infections (HAIs) in the United States. Applying two different Consumer Price Index (CPI) adjustments to account for the rate of inflation in hospital resource prices, the overall annual direct medical costs of HAI to U.S. hospitals ranges from $28.4 to $33.8 billion (after adjusting to 2007 dollars using the CPI for all urban consumers) and $35.7 billion to $45 billion (after adjusting to 2007 dollars using the CPI for inpatient hospital services). After adjusting for the range of effectiveness of possible infection control interventions, the benefits of prevention range from a low of $5.7 to $6.8 billion (20 percent of infections preventable, CPI for all urban consumers) to a high of $25.0 to $31.5 billion (70 percent of infections preventable, CPI for inpatient hospital services).

[1]  G. H. Moore,et al.  Consumer Price Index , 1993 .

[2]  S. Finkler.  The distinction between cost and charges. , 1982, Annals of internal medicine.

[3]  D. Dranove,et al.  Pricing by non-profit institutions. The case of hospital cost-shifting. , 1988, Journal of health economics.

[4]  R. Haley.  Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. , 1991, The American journal of medicine.

[5]  D. Farley,et al.  Payment source and the cost of hospital care: evidence from a multiproduct cost function with multiple payers. , 1996, Journal of health economics.

[6]  E. Cardenas.  Revision of the CPI hospital services component. , 1996, Monthly labor review.

[7]  Elaine Larson,et al.  A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. , 2002, American journal of infection control.

[8]  Victoria J. Fraser,et al.  Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* , 2003, Critical care medicine.

[9]  P Gastmeier,et al.  The preventable proportion of nosocomial infections: an overview of published reports. , 2003, The Journal of hospital infection.

[10]  W. Trick,et al.  The use of economic modeling to determine the hospital costs associated with nosocomial infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Sanjay Saint,et al.  Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Owings,et al.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. , 2006, Emerging infectious diseases.

[13]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[14]  J. Haas.  Measurement of infection control department performance: state of the science. , 2006, American journal of infection control.

[15]  R. Owens,et al.  Antimicrobial Resistance : Problem Pathogens and Clinical Countermeasures , 2007 .

[16]  W. Rutala,et al.  Comparison of Hospitalwide Surveillance and Targeted Intensive Care Unit Surveillance of Healthcare-Associated Infections , 2007, Infection Control & Hospital Epidemiology.

[17]  D. Anderson,et al.  Underresourced Hospital Infection Control and Prevention Programs: Penny Wise, Pound Foolish? , 2007, Infection Control & Hospital Epidemiology.

[18]  R. Chisin.  Cost-Effectiveness Analysis , 2009, Journal of Nuclear Medicine.